131 related articles for article (PubMed ID: 9231061)
41. Pancreatic polypeptide regulates glucagon release through PPYR1 receptors expressed in mouse and human alpha-cells.
Aragón F; Karaca M; Novials A; Maldonado R; Maechler P; Rubí B
Biochim Biophys Acta; 2015 Feb; 1850(2):343-51. PubMed ID: 25445712
[TBL] [Abstract][Full Text] [Related]
42. Metastatic glucagonoma: treatment with liver transplantation.
Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
[TBL] [Abstract][Full Text] [Related]
43. [Inhibitory effects of somatostatin analog (SMS 201-995) on pancreatic hormones in patients with malignant islet-cell carcinoma].
Fukushima H; Ueno S; Sakakida M; Takahashi T; Shirotani T; Araki E; Kishikawa H; Yamaguchi K; Nakamura N; Uzawa H
Nihon Naibunpi Gakkai Zasshi; 1988 Aug; 64(8):666-76. PubMed ID: 2852126
[TBL] [Abstract][Full Text] [Related]
44. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
[TBL] [Abstract][Full Text] [Related]
45. Differential sensitivity to somatostatin of pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas.
Hermansen K; Schwartz TW
Metabolism; 1979 Dec; 28(12):1229-33. PubMed ID: 514083
[TBL] [Abstract][Full Text] [Related]
46. Case report: diabetic ketoacidosis in a patient with glucagonoma.
Anthony LB; Sharp SC; May ME
Am J Med Sci; 1995 Jun; 309(6):326-7. PubMed ID: 7771503
[TBL] [Abstract][Full Text] [Related]
47. Effects of islet hormones on insulin secretion from cloned B cell lines, HIT-T15 and RINm5F.
Lambert DG; Atkins TW
J Endocrinol; 1989 Jun; 121(3):479-85. PubMed ID: 2569024
[TBL] [Abstract][Full Text] [Related]
48. The imidazoline NNC77-0020 affects glucose-dependent insulin, glucagon and somatostatin secretion in mouse pancreatic islets.
Høy M; Olsen HL; Bokvist K; Petersen JS; Gromada J
Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):284-93. PubMed ID: 13680090
[TBL] [Abstract][Full Text] [Related]
49. A case with glucagonoma syndrome--endocrine and metabolic studies.
Fukushima H; Yamaguchi K; Uzawa H; Kitoh M; Takemiya M; Konno T
Endocrinol Jpn; 1981 Apr; 28(2):111-25. PubMed ID: 6273136
[TBL] [Abstract][Full Text] [Related]
50. The metabolic effects of chronic hyperglucagonaemia.
Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
[TBL] [Abstract][Full Text] [Related]
51. Effects of insulin, glucagon, and somatostatin on the release of somatostatin-25 and somatostatin-14 from rainbow trout, Oncorhynchus mykiss, pancreatic islets in vitro.
Eilertson CD; Kittilson JD; Sheridan MA
Gen Comp Endocrinol; 1995 Aug; 99(2):211-20. PubMed ID: 8536932
[TBL] [Abstract][Full Text] [Related]
52. [An autopsy case of glucagonoma associated with production of several hormones].
Fujise K; Matsuura T; Nakagawa J; Egawa K; Hihara M; Nakahara M; Kawase H; Kitahara T; Ohara K; Joh K
Nihon Naika Gakkai Zasshi; 1988 Jun; 77(6):880-1. PubMed ID: 2906354
[No Abstract] [Full Text] [Related]
53. Synthetic gastric inhibitory polypeptide. Stimulatory effect on insulin and glucagon secretion in the rat.
Taminato T; Seino Y; Goto Y; Inoue Y; Kadowaki S
Diabetes; 1977 May; 26(5):480-4. PubMed ID: 323091
[TBL] [Abstract][Full Text] [Related]
54. Glucose generates coincident insulin and somatostatin pulses and antisynchronous glucagon pulses from human pancreatic islets.
Hellman B; Salehi A; Gylfe E; Dansk H; Grapengiesser E
Endocrinology; 2009 Dec; 150(12):5334-40. PubMed ID: 19819962
[TBL] [Abstract][Full Text] [Related]
55. [A case report of malignant glucagonoma with a profile of immunoreactive glucagon before and after the operation].
Ohtsuka K; Nimura Y; Takaesu H; Yokoi S; Shionoya S; Yasui K
Nihon Shokakibyo Gakkai Zasshi; 1986 Oct; 83(10):2223-6. PubMed ID: 3029475
[No Abstract] [Full Text] [Related]
56. Effects of gastric inhibitory polypeptide, vasoactive intestinal polypeptide and peptide histidine isoleucine on the secretion of hormones by isolated mouse pancreatic islets.
Bailey CJ; Wilkes LC; Conlon JM; Armstrong PH; Buchanan KD
J Endocrinol; 1990 Jun; 125(3):375-9. PubMed ID: 1973701
[TBL] [Abstract][Full Text] [Related]
57. Somatostatin and pancreatic polypeptide secretion: effects of glucagon, insulin, and arginine.
Weir GC; Samols E; Loo S; Patel YC; Gabbay KH
Diabetes; 1979 Jan; 28(1):35-40. PubMed ID: 759249
[TBL] [Abstract][Full Text] [Related]
58. A familial glucagonoma syndrome: genetic, clinical and biochemical features.
Stacpoole PW; Jaspan J; Kasselberg AG; Halter SA; Polonsky K; Gluck FW; Liljenquist JE; Rabin D
Am J Med; 1981 May; 70(5):1017-26. PubMed ID: 6112877
[TBL] [Abstract][Full Text] [Related]
59. A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal.
Parkinson C; Drake WM; Roberts ME; Meeran K; Besser GM; Trainer PJ
J Clin Endocrinol Metab; 2002 Apr; 87(4):1797-804. PubMed ID: 11932320
[TBL] [Abstract][Full Text] [Related]
60. Reversal of a neurologic paraneoplastic syndrome with octreotide (Sandostatin) in a patient with glucagonoma.
Holmes A; Kilpatrick C; Proietto J; Green MD
Am J Med; 1991 Oct; 91(4):434-6. PubMed ID: 1951389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
